# Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy

> **NCT01972724** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 114 (actual)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Metformin
- **DRUG:** Sulfonylurea

## Key facts

- **NCT ID:** NCT01972724
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-16
- **Primary completion:** 2016-10-17
- **Final completion:** 2016-10-17
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01972724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01972724, "Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01972724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*